Hans van Houte - 31 May 2022 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Chief Financial Officer
Signature
/s/ Christine Ring, as Attorney-in-Fact for Hans van Houte
Issuer symbol
NRIX
Transactions as of
31 May 2022
Net transactions value
+$57,400
Form type
4
Filing time
01 Jun 2022, 16:57:59 UTC
Previous filing
03 May 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRIX Common Stock Options Exercise $57,400 +68,333 +3122% $0.8400* 70,522 31 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Employee Stock Option (right to buy) Options Exercise $0 -68,333 -100% $0.000000* 0 31 May 2022 Common Stock 68,333 $0.8400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested.